Jazz Pharmaceuticals (JAZZ) Beats Q1 Earnings and Revenue Estimates

Jazz Pharmaceuticals (JAZZ) came out with quarterly earnings of $3.92 per share, beating the Zacks Consensus Estimate of $3.69 per share. This compares to earnings of $0.45 per share a year ago. These figures are adjusted for non-recurring items.